Enova International has withdrawn its applications to acquire Grasshopper Bancorp, citing unclear regulatory standards and political pressures. Despite this, Enova remains confident in its growth strategy and reaffirmed its 2026 revenue growth guidance of 20-25% and adjusted EPS growth of 30-35%. The company also plans to accelerate share repurchases, with $218 million available under senior note covenants and $349 million under board authorization. Enova emphasizes its commitment to serving consumers and small businesses underserved by traditional banks without becoming a bank itself.
Enova International's withdrawal of bank regulatory applications provides context for financial sector watchers. For readers following the financial sector, here is Pluang's market snapshot as of Sep 15, 2026 02:22 WIB: Among 74 priced Financials-sector US stocks tradable on Pluang, 28 rose and 46 fell today. Notable price changes include STM (STMicroelectronics NV) at USD 48.02 with a 1-day change of -6.78%, BAC (Bank of America Corp) at USD 59.08 down 5.77%, and GS (Goldman Sachs Group Inc) at USD 987.55 down 4.04%.
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer-grade humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Powered by AiMOGA's proprietary AI system MoAgent, Mobo can interpret complex command...
AiMOGA Robotics, a Chery brand, unveiled Mobo, its first consumer humanoid robot designed for home companionship, at the 2026 Chery International User Summit. Mobo uses advanced AI to understand complex commands, navigate home environments, and remem...
AiMOGA Robotics, a Chery brand, will debut Mobo, its first consumer-grade humanoid robot designed as a home companion, at the 2026 Chery International User Summit in Wuhu, China. Mobo features advanced AI for understanding complex commands, spatial a...
AiMOGA Robotics, a brand under Chery, introduced Mobo, its first consumer-grade humanoid robot designed as a family companion, at the 2026 Chery International User Summit. Mobo operates with AiMOGA's proprietary MoAgent AI, enabling it to understand ...
Ascendis Pharma announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of TransCon CNP (navepegritide), a once-weekly treatment for achondroplasia in children aged two and older with open growth plates...
